We are live on ! Find out more
DFTX

Definium Therapeutics
DFTX

176 hedge funds and large institutions have $72.4M invested in Definium Therapeutics in 2021 Q4 according to their latest regulatory filings, with 37 funds opening new positions, 54 increasing their positions, 35 reducing their positions, and 29 closing their positions.

New
Increased
Maintained
Reduced
Closed

121% more call options, than puts

Call options by funds: $5.21M | Put options by funds: $2.36M

54% more repeat investments, than reductions

Existing positions increased: 54 | Existing positions reduced: 35

28% more first-time investments, than exits

New positions opened: 37 | Existing positions closed: 29

1% more funds holding

Funds holding: 174 → 176 (+2)

0.05% less ownership

Funds ownership: 0.87% → 0.82% (-0.05%)

31% less capital invested

Capital invested by funds: $105M → $72.4M (-$32.4M)

Holders
176
Holders Change
+2
Holders Change %
+1.15%
% of All Funds
2.71%
Holding in Top 10
1
Holding in Top 10 Change
+1
Holding in Top 10 Change %
% of All Funds
0.02%
New
37
Increased
54
Reduced
35
Closed
29
Calls
$5.21M
Puts
$2.36M
Net Calls
+$2.85M
Net Calls Change
+$1.65M

Top Buyers

1
Morgan Stanley
Morgan Stanley
New York
+$4.69M
2
Citadel Advisors
Citadel Advisors
Florida
+$2.96M
3
Two Sigma Investments
Two Sigma Investments
New York
+$1.68M
4
BB
Busey Bank
Illinois
+$918K
5
BlackRock
BlackRock
New York
+$816K

Top Sellers

1
Goldman Sachs
Goldman Sachs
New York
-$1.68M
2
MI
MMCAP International
Cayman Islands
-$759K
3
Millennium Management
Millennium Management
New York
-$673K
4
Simplex Trading
Simplex Trading
Illinois
-$362K
5
SC
Shay Capital
New York
-$329K
Name Holding Trade Value Shares
Change 		Change in
Stake
AGAM
51
Audent Global Asset Management
California
$108K +$166K +5,200 New
MLICM
52
Metropolitan Life Insurance Company (MetLife)
New York
$107K +$13.6K +427 +9%
ProShare Advisors
53
ProShare Advisors
Maryland
$105K +$66.8K +2,094 +70%
GG
54
Gofen & Glossberg
Illinois
$100K – – –
HSBC Holdings
55
HSBC Holdings
United Kingdom
$93K +$21.5K +675 +36%
GSC
56
Ground Swell Capital
South Carolina
$88K +$136K +4,247 New
SG Americas Securities
57
SG Americas Securities
New York
$86K -$168K -5,259 -56%
Principal Financial Group
58
Principal Financial Group
Iowa
$82K -$29.4K -921 -19%
AGM
59
Alpine Global Management
New York
$82K +$127K +3,979 New
HighTower Advisors
60
HighTower Advisors
Illinois
$81K -$113K -3,531 -47%
Creative Planning
61
Creative Planning
Kansas
$80K -$38.6K -1,210 -24%
XT
62
XTX Topco
Cayman Islands
$79K +$123K +3,841 New
Legal & General Group
63
Legal & General Group
United Kingdom
$78K +$1.72K +54 +2%
Two Sigma Advisers
64
Two Sigma Advisers
New York
$78K +$120K +3,760 New
Parallax Volatility Advisers
65
Parallax Volatility Advisers
California
$74K +$114K +3,571 New
State Board of Administration of Florida Retirement System
66
State Board of Administration of Florida Retirement System
Florida
$66K +$192 +6 +0.2%
Stifel Financial
67
Stifel Financial
Missouri
$64K +$2.68K +84 +3%
Toronto Dominion Bank
68
Toronto Dominion Bank
Ontario, Canada
$56K +$2.33K +73 +3%
JMPWA
69
JP Morgan Private Wealth Advisors
California
$52K -$10.3K -322 -11%
SAM
70
Shell Asset Management
Netherlands
$52K +$19.5K +611 +32%
JIP
71
Jaffetilchin Investment Partners
Florida
$51K – – –
WS
72
Wedbush Securities
California
$50K +$28.7K +900 +60%
TSS
73
Two Sigma Securities
New York
$50K +$77.3K +2,423 New
Wolverine Trading
74
Wolverine Trading
Illinois
$48K +$13K +406 +22%
Squarepoint
75
Squarepoint
New York
$48K +$49.8K +1,559 +205%
1 2
3
4 5

DFTX Hedge Fund Activity: Q4 2021 in Review

176 of the 6,498 institutional investors tracked by Wall St. Rank reported a position in Definium Therapeutics (DFTX) for Q4 2021, worth a combined $72.4M — down 31% from $105M a quarter earlier.

Buyers outnumbered sellers: 37 funds opened new DFTX positions and 29 closed out — a net gain of 8 holders — while 54 added to existing stakes and 35 trimmed.

The largest buyer was Morgan Stanley, adding an estimated $4.69M. The largest seller was Goldman Sachs, cutting an estimated $1.68M.

  • 176 institutional investors held Definium Therapeutics (DFTX) as of Q4 2021, up from 174 in Q3 2021.
  • Funds reported $72.4M of Definium Therapeutics stock for Q4 2021, down 31% quarter-over-quarter.
  • 37 funds opened new Definium Therapeutics positions in Q4 2021 and 29 closed out, a net change of +8 holders.
  • The largest Definium Therapeutics buyer in Q4 2021 was Morgan Stanley, an estimated $4.69M added.
  • The largest Definium Therapeutics seller in Q4 2021 was Goldman Sachs, an estimated $1.68M sold.

Based on aggregated 13F filings for Q4 2021.